Get ready for this winter’s respiratory virus trifecta

Ben Falkenmire

writer

Ben Falkenmire

Writer

Ben Falkenmire

 

As we approach winter with no mandatory masks or isolation laws, and COVID-19, the flu and RSV all looming—what can we do to minimise widespread infection and protect high-risk patients?

Associate Professor Paul Griffin, Director of Infectious Diseases at Mater Health and senior lecturer at the University of Queensland says the key is in the prep.

“This year is hard to predict. We know for certain that we will have all three viruses circulating again, and potentially all at once, so we need to be prepared,” Associate Professor Griffin says.

Enhanced flu vaccinations could help patients to avoid getting sick. Professor Griffin says two augmented vaccines are potentially 20-25% more effective among the elderly than the regular flu vaccine.

“Definitely use the augmented vaccines for the elderly, and it doesn’t matter which augmented vaccine they get,” he says.

“There is also a cell-based vaccine that isn’t grown in eggs, which some patients may like the sound of, but it’s not currently subsidised so there is a cost differential to consider.”

ATAGI recently recommended an additional COVID-19 vaccine booster for the elderly and those with comorbidities, with bivalent mRNA vaccines the preferred choice.

Pink background with syringe collecting fluid from test container vaccine image

Associate Professor Griffin advises GPs to have a low threshold for testing for all three viruses, particularly in high risk patients and those who could benefit from antiviral medications.

“Test with a multiplex panel for the flu, COVID-19, RSV and other viruses, like parainfluenza, so you can give patients timely access to antivirals and advice on how to manage their case and to control spreading it to others,” he says.

Growing misinformation among patients around COVID-19 and the flu is another factor GPs are expected to face in consults this winter.

Associate Professor Griffin says some patients may need reminding about the effectiveness of vaccines, to stay at home if unwell, and for high risk people, the benefits of wearing masks in public and having an antiviral plan in place.

“Given that we want high rates of uptake of both the COVID and flu vaccines, we need people to understand the viruses are a risk,” he says.

For more from Associate Professor Paul Griffin on what we’re up against this winter, and what can be done at the primary care level to mitigate the risks, sign up for Healthed’s FREE webcast this Tuesday, 21 February. Register here to attend.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Gary Wittert

Prof Gary Wittert

The Peptide Craze – What You Need to Know

Prof Andrew Sindone AM

Prof Andrew Sindone AM

Managing Acute Heart Failure After Discharge: A Practical Guide for GPs

A/Prof Gino Pecoraro OAM

A/Prof Gino Pecoraro OAM

Oral Contraceptives on the PBS – A Practical Guide for GPs

Dr Terri Foran

Dr Terri Foran

The Impact of PFAS & Other Endocrine Disrupting Chemicals on Fertility

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Ben Falkenmire

writer

Ben Falkenmire

Writer

Test your knowledge

Recent articles

Latest GP poll

In the last twelve months, how many adverse outcomes have you encountered arising from pharmacy prescribing?

None

0%

1-2

0%

Three or more

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.